Moseley Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.44M Buy
6,928
+33
+0.5% +$11.8K 0.78% 35
2025
Q4
$2.26M Sell
6,895
-69
-1% -$21.9K 0.7% 34
2025
Q3
$1.97M Buy
6,964
+234
+3% +$67.9K 0.6% 44
2025
Q2
$1.88M Buy
6,730
+295
+5% +$83.6K 0.65% 40
2025
Q1
$2M Buy
6,435
+296
+5% +$87.4K 0.78% 33
2024
Q4
$1.6M Buy
6,139
+24
+0.4% +$7.12K 0.62% 40
2024
Q3
$1.97M Sell
6,115
-90
-1% -$29.4K 0.79% 30
2024
Q2
$1.94M Buy
6,205
+49
+0.8% +$14.4K 0.9% 28
2024
Q1
$1.75M Buy
6,156
+234
+4% +$68.5K 0.87% 30
2023
Q4
$1.71M Buy
5,922
+71
+1% +$19.3K 0.95% 24
2023
Q3
$1.57M Buy
5,851
+40
+0.7% +$9.98K 0.94% 26
2023
Q2
$1.29M Buy
5,811
+47
+0.8% +$10.9K 0.75% 35
2023
Q1
$1.39M Buy
5,764
+32
+0.6% +$7.86K 0.9% 29
2022
Q4
$1.51M Buy
5,732
+41
+0.7% +$11K 1.08% 27
2022
Q3
$1.28M Sell
5,691
-2
-0% -$485 0.94% 30
2022
Q2
$1.39M Sell
5,693
-814
-13% -$199K 0.97% 30
2022
Q1
$1.57M Sell
6,507
-382
-6% -$87.8K 0.85% 35
2021
Q4
$1.55M Buy
6,889
+1,277
+23% +$270K 0.7% 47
2021
Q3
$1.2M Buy
5,612
+425
+8% +$97.8K 0.6% 48
2021
Q2
$1.26M Buy
5,187
+248
+5% +$61K 0.62% 46
2021
Q1
$1.23M Buy
4,939
+611
+14% +$146K 0.68% 44
2020
Q4
$995K Buy
4,328
+1,435
+50% +$331K 0.58% 54
2020
Q3
$735K Buy
2,893
+302
+12% +$74.8K 0.52% 55
2020
Q2
$611K Sell
2,591
-84
-3% -$19.2K 0.51% 59
2020
Q1
$542K Buy
2,675
+269
+11% +$58.8K 0.64% 52
2019
Q4
$580K Buy
2,406
+69
+3% +$15.2K 0.57% 53
2019
Q3
$452K Buy
2,337
+1,078
+86% +$207K 0.47% 61
2019
Q2
$232K Sell
1,259
-195
-13% -$34.9K 0.22% 116
2019
Q1
$276K Buy
+1,454
New +$278K 0.29% 96

Other funds holding AMGN

Moseley Investment Management's AMGN Position: Q1 2026 in Review

Moseley Investment Management increased its Amgen (AMGN) stake by 0.48% in Q1 2026, buying an estimated $11.8K and bringing the position to 6,928 shares worth $2.44M. The position accounts for 0.78% of the portfolio, ranked #35.

Moseley Investment Management first reported a position in AMGN in Q1 2019 and has held it in 29 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Moseley Investment Management held 6,928 shares of Amgen worth $2.44M as of Q1 2026.
  • Moseley Investment Management bought 33 Amgen shares in Q1 2026, an estimated $11.8K.
  • Amgen made up 0.78% of Moseley Investment Management's portfolio in Q1 2026, its #35 holding.
  • Moseley Investment Management first reported a position in Amgen in Q1 2019 and has held it in 29 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Moseley Investment Management's 13F filing for Q1 2026, filed 21 Apr 2026.